|Bid||27.36 x 1000|
|Ask||31.43 x 800|
|Day's Range||29.73 - 30.27|
|52 Week Range||24.96 - 38.64|
|Beta (5Y Monthly)||1.33|
|PE Ratio (TTM)||34.22|
|Earnings Date||Feb 05, 2020|
|Forward Dividend & Yield||0.38 (1.27%)|
|Ex-Dividend Date||Mar 01, 2020|
|1y Target Est||36.00|
Investors continue to be optimistic about Zimmer's (ZBH) potential on its strong segmental and international results for the fiscal fourth quarter.
There's been a notable change in appetite for LeMaitre Vascular, Inc. (NASDAQ:LMAT) shares in the week since its...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (NASDAQ: ...
LeMaitre (LMAT) delivered earnings and revenue surprises of 0.00% and -1.05%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
BURLINGTON, Mass., Feb. 06, 2020 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2019 results, provided.
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BURLINGTON, Mass., Jan. 29, 2020 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2019 financial results on Thursday, February.
For many, the main point of investing in the stock market is to achieve spectacular returns. And highest quality...
The human circulatory system is amazing. But it doesn't always run smoothly. Roughly 3% of the living population suffers from some sort of peripheral vascular disease (PVD), explains Tyler Laundon, editor of Cabot Small-Cap Confidential.
BURLINGTON, Mass., Jan. 03, 2020 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 22nd Annual Needham.
If you own shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) then it's worth thinking about how it contributes to the...
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms' equity portfolios as of September 30th. The results of that effort will be put on display in this article, as […]
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Could LeMaitre Vascular, Inc. (NASDAQ:LMAT) be an attractive dividend share to own for the long haul? Investors are...
BURLINGTON, Mass., Nov. 15, 2019 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at two conferences in November. David Roberts, President,.
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]
Anyone interested in LeMaitre Vascular, Inc. (NASDAQ:LMAT) should probably be aware that the Chairman & CEO, George...